Lihat Juga

Impact of new biomarkers of myocardial damage on trends in myocardial infarction hospital admission rates from population-based administrative data

Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men

[s.l.] : [s.n.] : s.a.]

Indeks Artikel Jurnal-Majalah

Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction

[s.l.] : [s.n.] : s.a.]

Indeks Artikel Jurnal-Majalah

Effects of n - 3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction

Erik J. Giltay, Johanna M. Geleijnse, Daan Kromhout

[s.l.] : [s.n.] : 2011

Indeks Artikel Jurnal-Majalah

Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction : importance of the glycemic index

[s.l.] : [s.n.] : s.a.]

Indeks Artikel Jurnal-Majalah

A novel fatty acid profile index - the lipophilic index - and risk of myocardial infarction

Estefania Toledo ... [et al.]

Oxford : Oxford University Press, 2013

Indeks Artikel Jurnal-Majalah

Baldness and myocardial infarction in men the atherosclerosis risk in communities study

by Eyal Shahar ... [et al]

Baltimore : Johns Hopkins Bloomberg School of Public Health, 2008

Indeks Artikel Jurnal-Majalah

Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Compositional models for mortality by age, sex and cause, Joshua A Salomon; 2. The epidemiological transitional: policy and planning implications for developing countries, James N. Gribble; 3. Methodology for measuring health-state preferences - 1: measurement strategies, Debra G. Froberg; 4. Methodology for measuring health-State preferences - II: scaling methods, Debra G. Froberg; 5. Methodology for measuring health-State preferences - III: population and context effects, Debra G. Froberg; 5. Measurement of health state utilities for economic appraisal : a review, George W. Torrance; 7. Methods for quality adjusment of life years, Erik Nord; 8. The person-trade-off approach to valuing health care programs, Erik Nord; 9. Cost utility analysis: what should be measured?, J. Richardson; 10. Health state valuations from the general public using the visual analogue scale, C Gudex; 11. Modeling valuations for EuroQol health states, Paul Dolan; 12. Deriving preference-based single index from the UK SF-36 health survey, John Brazier; 13. Measuring preferences for health states worse than death, Donald L. Patrick; 14. Multiattribute utility function for a comprehensive health status classification system health utilities index mark 2, George W. Torrance; 15. Evaluating healthy days of life gained from health projects, Howard Barnum; 16. The utility of health at different stages in life: a quantitative approach, Jan J. V.B; 17. The economic cost of illness revisited, Barbara S. Cooper; 18. Is the valuation of a qaly gained independent of age? some empirical evidence, Magnus J; 19. Discounting in the economic evaluation of health care interventions, Murray K; 20. Maximizing health benefits vs egalitarianism: an Australian survey of health issues, Erik N; 21. Estimating the cost of illness, Dorothy P.R.; 22. Discounting in health care decision-making: time for a change ?, Trevor A. Sheldon; 23. Discounting the future: influence of the economic model, Robert R. West; 24. Penn world tables 5.6, Alan H; 25. On the comparable quantification of health risks: lessons from the global burden of disease study, Christophr J.L.M; 26. Conceptual problems in the definition and interprtation of attributable fractions, Sander G; 27. Estimability and estimation of excess and etiologic fractions, James M. Robin; 28. Reducing the global burden of blood pressure-related cardiovascular disease, Anthony R; 29. The Australian burden of disease study: measuring the loss of health from diseses, injuries and risk factors, Colin DM; 30. Mortality in relation to smoking: 40 years' observations on male British doctors, Richard D; 31. Estimated numbers of deaths from coronary heart disease "Caused" and "prevented" by alcohol: an example from Finland, Pia M; 32. Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Richard P.A; 33. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men, Pirjo Pietinen; 34. Alcohol consumption and mortality among middle-aged and elderly U.S. adults, Michael J. Thun; 35. An improved aetiologic fraction of alcohol caused morbidity and mortality; 36. Dietary fat intake and the risk of coronary heart disease in women, Frank B. Hu; 37. Obesity, mortality and cardiovascular disease in the munster heart study (PROCAM), Helmut S; 38. The burden of dsease in Mexico in 1994: advances and challenges, Rafael Lozano; 39. The burden of disease and injury in Australia, Colin Mathers)

[s.l.] : Geneva: WHO, 2000, s.a.]

Prosiding

Cellular cardiomyoplasty for myocardial infarction : a 2014 evidence-based update

Alvin Nursalim, Puspita A. Katili, Teguh Santoso

Jakarta : Faculty of Medicine Universitas Indonesia, 2014

Indeks Artikel Jurnal-Majalah

Determinants of reduced child stunting in Cambodia: analysis of pooled data from three demographic and health surveys

[s.l.] : [s.n.] : s.a.]

Indeks Artikel Jurnal-Majalah